Statera Biopharma, Inc. Accumulated Other Comprehensive Income
Statera Biopharma, Inc. had Accumulated Other Comprehensive Income of $53.70 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2022-11-14
- 2022-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $53.70K.
- 2022-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $25.17K.
- 2022-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$24.25K.
- 2021-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$6.65K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2022-09-30 | $53.70K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $25.17K 10-Q · filed 2022-10-28 |
| 2022-03-31 | -$24.25K 10-Q · filed 2022-10-21 |
| 2021-12-31 | -$6.65K 10-Q · filed 2022-11-14 |
| 2021-09-30 | -$2.01K 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$681.82K 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$690.86K 10-Q · filed 2021-05-14 |
| 2020-12-31 | -$685.68K 10-Q · filed 2021-08-16 |
| 2020-12-30 | $0.00 10-Q · filed 2021-11-15 |
| 2020-09-30 | -$645.02K 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$612.12K 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$642.51K 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$568.03K 10-K · filed 2021-03-22 |
| 2019-09-30 | -$582.90K 10-Q · filed 2019-11-14 |
| 2019-06-30 | -$574.74K 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$584.61K 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$611.37K 10-K · filed 2020-04-15 |
| 2018-09-30 | -$588.90K 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$565.10K 10-Q · filed 2018-08-14 |
| 2018-03-31 | -$510.30K 10-Q · filed 2018-05-15 |
| 2017-12-31 | -$516.46K 10-K · filed 2019-03-07 |
| 2017-09-30 | -$521.65K 10-Q · filed 2017-11-14 |
| 2017-06-30 | -$539.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$497.58K 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$564.56K 10-K · filed 2018-03-06 |
| 2016-09-30 | -$407.59K 10-Q · filed 2016-11-14 |
| 2016-06-30 | -$409.93K 10-Q · filed 2016-08-15 |
| 2016-03-31 | -$407.90K 10-Q · filed 2016-05-16 |
| 2015-12-31 | -$408.05K 10-K · filed 2017-02-22 |
| 2015-09-30 | -$465.72K 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$425.46K 10-Q · filed 2015-08-12 |
| 2015-03-31 | -$450.17K 10-Q · filed 2015-05-07 |
| 2014-12-31 | -$380.11K 10-K · filed 2016-02-23 |
| 2014-09-30 | -$201.21K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $236.50K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $117.32K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $307.34K 10-K · filed 2015-02-27 |
| 2013-09-30 | $307.41K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $288.47K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $454.28K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $546.47K 10-K · filed 2014-03-17 |
| 2012-09-30 | $463.66K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $125.74K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $500.16K 10-Q · filed 2012-05-07 |
| 2011-12-31 | $84.61K 10-K · filed 2013-03-18 |
| 2011-09-30 | -$81.86K 10-Q/A · filed 2011-11-14 |
| 2011-06-30 | $160.71K 10-Q · filed 2011-08-09 |
| 2010-12-31 | -$30.54K 10-K · filed 2012-03-13 |